Dexcom (DXCM) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Dexcom (DXCM) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 43.57% |
| 10 | Zimmer Biomet Holdings | 19.24 Bn | 18.83 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.70% |
| Mar 31, 2026 | 100.22% |
| Dec 31, 2025 | 21.45% |
| Sep 30, 2025 | -17.02% |
| Jun 30, 2025 | 96.93% |
| Mar 31, 2025 | 83.02% |
| Dec 31, 2024 | 411.06% |
| Sep 30, 2024 | -25.16% |
| Jun 30, 2024 | -7.21% |
| Mar 31, 2024 | 31.05% |
| Dec 31, 2023 | 162.77% |
| Sep 30, 2023 | 209.35% |
| Jun 30, 2023 | 86.63% |
| Mar 31, 2023 | 67.54% |
| Dec 31, 2022 | 76.87% |
| Sep 30, 2022 | 100.97% |
| Jun 30, 2022 | 383.54% |
| Mar 31, 2022 | 89.47% |
| Dec 31, 2021 | 26.06% |
| Sep 30, 2021 | 108.51% |